Evidence map›Paper›PMID 30078221›Full record

ArticleJournal of cellular physiology2018

Novel role of Giα2 in cell migration: Downstream of PI3-kinase-AKT and Rac1 in prostate cancer cells.

Silvia Caggia, HimaBindu Chunduri, Ana C Millena, Jonathan N Perkins, Smrruthi V Venugopal, BaoHan T Vo, Chunliang Li, Yaping Tu, Shafiq A Khan

Abstract read
In one paragraph

Article in Journal of cellular physiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. GαInternational journal of molecular sciences · 2025
    Article
  3. Article
  4. Review
  5. Development and validation of a sensitive LC-MS/MS assay of GT-14, a novel GαJournal of pharmaceutical and biomedical analysis · 2024
    Article
  6. GαCancers · 2024
    Article
  7. Review
  8. Article
  9. Article
  10. Update onCancers · 2020
    Review
  11. Article
  12. Review
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Silvia CaggiaCenter for Cancer Research and Therapeutic Development, Clark Atlanta University, Atlanta, Georgia.
HimaBindu ChunduriCenter for Cancer Research and Therapeutic Development, Clark Atlanta University, Atlanta, Georgia.
Ana C MillenaCenter for Cancer Research and Therapeutic Development, Clark Atlanta University, Atlanta, Georgia.
Jonathan N PerkinsCenter for Cancer Research and Therapeutic Development, Clark Atlanta University, Atlanta, Georgia.
Smrruthi V VenugopalCenter for Cancer Research and Therapeutic Development, Clark Atlanta University, Atlanta, Georgia.
BaoHan T VoDepartment of Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, Tennessee.
Chunliang LiDepartment of Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, Tennessee.
Yaping TuDepartment of Pharmacology, Creighton University School of Medicine, Omaha, Nebraska.
Shafiq A KhanCenter for Cancer Research and Therapeutic Development, Clark Atlanta University, Atlanta, Georgia.ORCID 0000-0002-1010-313X
Center for Cancer Research · USSt. Jude Children's Research Hospital · USCreighton University · US

Funding

TRAINNING COREP20MD002285 · NIMHD · CLARK ATLANTA UNIVERSITY · PI KHAN, SHAFIQ A · 2007 to 2016
$10.9M
Technologies/Resources for Core LaboratoriesG12MD007590 · NIMHD · CLARK ATLANTA UNIVERSITY · PI KHAN, SHAFIQ A · 2012 to 2018
$7.6M
NIMHD NIH HHS G12 MD007590NIMHD NIH HHS P20 MD002285
6 · The paper itself

Abstract

Tumor cell motility is the essential step in cancer metastasis. Previously, we showed that oxytocin and epidermal growth factor (EGF) effects on cell migration in prostate cancer cells require Giα2 protein. In the current study, we investigated the interactions among G-protein coupled receptor (GPCR), Giα2, PI3-kinase, and Rac1 activation in the induction of migratory and invasive behavior by diverse stimuli. Knockdown and knockout of endogenous Giα2 in PC3 cells resulted in attenuation of transforming growth factor β1 (TGFβ1), oxytocin, SDF-1α, and EGF effects on cell migration and invasion. In addition, knockdown of Giα2 in E006AA cells attenuated cell migration and overexpression of Giα2 in LNCaP cells caused significant increase in basal and EGF-stimulated cell migration. Pretreatment of PC3 cells with Pertussis toxin resulted in attenuation of TGFβ1- and oxytocin-induced migratory behavior and PI3-kinase activation without affecting EGF-induced PI3-kinase activation and cell migration. Basal- and EGF-induced activation of Rac1 in PC3 and DU145 cells were not affected in cells after Giα2 knockdown. On the other hand, Giα2 knockdown abolished the migratory capability of PC3 cells overexpressing constitutively active Rac1. The knockdown or knockout of Giα2 resulted in impaired formation of lamellipodia at the leading edge of the migrating cells. We conclude that Giα2 protein acts at two different levels which are both dependent and independent of GPCR signaling to induce cell migration and invasion in prostate cancer cells and its action is downstream of PI3-kinase-AKT-Rac1 axis.

Indexed as

Cell Line, TumorCell MovementCell ProliferationChemokine CXCL12Epidermal Growth FactorGene Expression Regulation, NeoplasticGTP-Binding Protein alpha Subunits, Gi-GoHumansMaleNeoplasm InvasivenessOncogene Protein v-aktOxytocinPhosphatidylinositol 3-KinasesPhosphorylationProstateProstatic NeoplasmsChemokine CXCL12CXCL12 protein, humanEpidermal Growth FactorGTP-Binding Protein alpha Subunits, Gi-GoOncogene Protein v-aktOxytocinPhosphatidylinositol 3-Kinasesrac1 GTP-Binding ProteinRAC1 protein, humanTGFB1 protein, humanTransforming Growth Factor beta1epidermal growth factorF-actinG-protein coupled receptorslamellipodiamigration

Identifiers

PMID30078221
PMCPMC6202161
OpenAlexW2886487711

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.